Ewing tumors of the head and neck

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 33, Issue 4, 2010, Pages 321-326

  Whaley, J Taylor ^a   Indelicato, Daniel J ^a,b   Morris, Christopher G ^a   Hinerman, Russell W ^a   Amdur, Robert J ^a   Mendenhall, William M ^a,b   Keole, Sameer R ^a,b   Marcus Jr , Robert B ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Cranial; Ewing family of tumors; Ewing's sarcoma; Head and neck; Radiation therapy

Indexed keywords

CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; VINCRISTINE; ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; ARTICLE; CALVARIA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CATARACT; CAUSE SPECIFIC SURVIVAL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DEHYDRATION; DENTITION; EVENT FREE SURVIVAL; EWING SARCOMA; EXTERNAL OTITIS; FEMALE; FOLLOW UP; HEAD AND NECK TUMOR; HUMAN; MALE; MANDIBLE; MANDIBLE HYPOPLASIA; MEDICAL LITERATURE; MEDICAL RECORD REVIEW; MICROGNATHIA; MOUTH CAVITY; MUCOSA INFLAMMATION; OVERALL SURVIVAL; PAPILLEDEMA; PARANASAL SINUS; PRESCHOOL CHILD; PROBABILITY; RETROSPECTIVE STUDY; SCHOOL CHILD; SOFT TISSUE; TUMOR LOCALIZATION; VISUAL IMPAIRMENT; XEROPHTHALMIA; MORTALITY; MULTIMODALITY CANCER THERAPY; RADIATION DOSE; REVIEW; SURVIVAL; SURVIVAL RATE; TIME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SARCOMA, EWING'S; SURVIVAL ANALYSIS; SURVIVAL RATE; TIME FACTORS;

EID: 77956636117     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e3181aaca71     Document Type: Article

References (40)

1. La TH, Meyers PA, Wexler LH, et al. Radiation therapy for Ewing's sarcoma: Results from Memorial Sloan-Kettering in the modern era. Int J Radiat Oncol Biol Phys. 2006;64:544-550.
2. Kutluk MT, Yalcin B, Akyuz C, et al. Treatment results and prognostic factors in Ewing sarcoma. Pediatr Hematol Oncol. 2004;21:597-610.
3. Fizazi K, Dohollou N, Blay JY, et al. Ewing's family of tumors in adults: Multivariate analysis of survival and long-term results of multimodality therapy in 182 patients. J Clin Oncol. 1998;16:3736-3743.
4. Paulino AC, Nguyen TX, Mai WY, et al. Dose response and local control using radiotherapy in nonmetastatic Ewing sarcoma. Pediatr Blood Cancer. 2007;49:145-148.
5. Paulino AC, Nguyen TX, Mai WY. An analysis of primary site control and late effects according to local control modality in nonmetastatic Ewing sarcoma. Pediatr Blood Cancer. 2007;48:423-429.
6. Grier HE, Krailo MD, Tarbell NJ, et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med. 2003;348:694-701.
7. Burgert EO Jr, Nesbit ME, Garnsey LA, et al. Multimodal therapy for the management of nonpelvic, localized Ewing's sarcoma of bone: Intergroup Study IESS II. J Clin Oncol. 1990;8:1514-1524.
8. Daw HA, Markman M. Epidural spinal cord compression in cancer patients: Diagnosis and management. Cleve Clin J Med. 2000;67:497, 501-497, 504.
9. Siegal GP, Oliver WR, Reinus WR, et al. Primary Ewing's sarcoma involving the bones of the head and neck. Cancer. 1987;60:2829-2840.
10. Allam A, El Husseiny G, Khafaga Y, et al. Ewing's Sarcoma of the Head and Neck: A retrospective analysis of 24 cases. Sarcoma. 1999;3:11-15.
11. Raney RB, Asmar L, Vassilopoulou-Sellin R, et al; IRS Group of the Children's Cancer Group and the Pediatric Oncology Group. Late complications of therapy in 213 children with localized, nonorbital soft-tissue sarcoma of the head and neck: A descriptive report from the Intergroup Rhabdomyosarcoma Studies (IRS)-II and-III. Med Pediatr Oncol. 1999;33:362-371.
12. Solomon LW, Frustino JL, Loree TR, et al. Ewing sarcoma of the mandibular condyle: Multidisciplinary management optimizes outcome. Head Neck. 2008;30:405-410.
13. Ozaki T, Hillmann A, Hoffmann C, et al. Significance of surgical margin on the prognosis of patients with Ewing's sarcoma: A report from the Cooperative Ewing's Sarcoma Study. Cancer. 1996;78:892-900.
14. Wexler LH, Delaney TF, Tsokos M, et al. Ifosamide and etoposide plus vincristine, dozorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors. Cancer. 1996;78:901-911.
15. Schuck A, Hofmann J, Rube C, et al. Radiotherapy in Ewing's sarcoma and PNET of the chest wall: Results of the trials CESS 81, CESS 86, and EICESS 92. Int J Radiat Oncol Biol Phys. 1998;42:1001-1006.
16. Indelicato DJ, Keole SR, Shahlaee AH, et al. Definitive radiotherapy for ewing tumors of extremities and pelvis: Long-term disease control, limb function, and treatment toxicity. Int J Radiat Oncol Biol Phys. 2008;72:871-877.
17. Indelicato DJ, Keole SR, Shahlaee AH, et al. Impact of local management on long-term outcomes in ewing tumors of the pelvis and sacral bones: The University of Florida Experience. Int J Radiat Oncol Biol Phys. 2008;72: 41-48.
18. Razek A, Perez CA, Tefft M, et al. Intergroup Ewing's Sarcoma Study: Local control related to radiation dose, volume, and site of primary lesion in Ewing's sarcoma. Cancer. 1980;46:516-521.
19. Desai KI, Nadkarni TD, Goel A, et al. Primary Ewing's sarcoma of the cranium. Neurosurgery. 2000;46:62-68.
20. Pfeiffer J, Boedeker CC, Ridder GJ. Primary Ewing sarcoma of the petrous temporal bone: An exceptional cause of facial palsy and deafness in a nursling. Head Neck. 2006;28:955-959.
21. Fiorillo A, Tranfa F, Canale G, et al. Primary Ewing's sarcoma of the maxilla, a rare, and curable localization: Report of two new cases, successfully treated by radiotherapy and systemic chemotherapy. Cancer Lett. 1996;103:177-182. (Pubitemid 26147696)
22. Dunst J, Jürgens H, Sauer R, et al. Radiation therapy in Ewing's sarcoma: An update of the CESS 86 trial. Int J Radiat Oncol Biol Phys. 1995;32:919-930.
23. Vaccani JP, Forte V, de Jong AL, et al. Ewing's sarcoma of the head and neck in children. Int J Pediatr Otorhinolaryngol. 1999;48:209-216.
24. Falk S, Alpert M. Five-year survival of patients with Ewing's sarcoma. Surg Gynecol Obstet. 1967;124:319-324.
25. Bacci G, Longhi A, Ferrari S, et al. Prognostic factors in nonmetastatic Ewing's sarcoma tumor of bone: An analysis of 579 patients treated at a single institution with adjuvant or neoadjuvant chemotherapy between 1972 and 1998. Acta Oncol. 2006;45:469-475. (Pubitemid 43884616)
26. Rosen G, Caparros B, Nirenberg A, et al. Ewing's sarcoma: Ten-year experience with adjuvant chemotherapy. Cancer. 1981;47:2204-2213.
27. Hadfield MG, Luo VY, Williams RL, et al. Ewing's sarcoma of the skull in an infant: A case report and review. Pediatr Neurosurg. 1996;25:100-104.
28. Zenke K, Hatakeyama T, Hashimoto H, et al. Primary Ewing's sarcoma of the occipital bone-case report. Neurol Med Chir (Tokyo). 1994;34:246-250.
29. Bacchini P, Marchetti C, Mancini L, et al. Ewing's sarcoma of the mandible and maxilla: A report of three cases from the Istituto Beretta. Oral Surg Oral Med Oral Pathol. 1986;61:278-283.
30. Wexler LH, Kacker A, Piro JD, et al. Combined modality treatment of Ewing's sarcoma of the maxilla. Head Neck. 2003;25:168-172.
31. Infante-Cossio P, Gutierrez-Perez JL, Garcia-Perla A, et al. Primary Ewing's sarcoma of the maxilla and zygoma: Report of a case. J Oral Maxillofac Surg. 2005;63:1539-1542.
32. Dunst J, Schuck A. Role of radiotherapy in Ewing tumors. Pediatr Blood Cancer. 2004;42:465-470.
33. Dehner LP. Tumors of the mandible and maxilla in children. II: A study of 14 primary and secondary malignant tumors. Cancer. 1973;32:112-120.
34. Watanabe H, Tsubokawa T, Katayama Y, et al. Primary Ewing's sarcoma of the temporal bone. Surg Neurol. 1992;37:54-58.
35. Steinbok P, Flodmark O, Norman MG, et al. Primary Ewing's sarcoma of the base of the skull. Neurosurgery. 1986;19:104-107.
36. Krasin MJ, Rodriguez-Galindo C, Billups CA, et al. Definitive irradiation in multidisciplinary management of localized Ewing sarcoma family of tumors in pediatric patients: Outcome and prognostic factors. Int J Radiat Oncol Biol Phys. 2004;60:830-838.
37. Bacci G, Forni C, Longhi A, et al. Long-term outcome for patients with nonmetastatic Ewing's sarcoma treated with adjuvant and neoadjuvant chemotherapies. Four hundred two patients treated at Rizzoli between 1972 and 1992. Eur J Cancer. 2004;40:73-83.
38. Paulino AC. Late effects of radiotherapy for pediatric extremity sarcomas. Int J Radiat Oncol Biol Phys. 2004;60:265-274.
39. Abudu A, Mangham DC, Reynolds GM, et al. Overexpression of p53 protein in primary Ewing's sarcoma of bone: Relationship to tumour stage, response and prognosis. Br J Cancer. 1999;79:1185-1189.
40. de Alava E, Kawai A, Healey JH, et al. EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma. J Clin Oncol. 1998;16:1248-1255.